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Abstract
Rheumatoid arthritis is a clinically and genetically heterogeneous disease. Anti-cyclic citrullinated
(anti-CCP) antibodies have a high specificity for rheumatoid arthritis and levels correlate with
disease severity. The focus of this study was to examine whether analyzing anti-CCP levels could
increase the power of linkage analysis by identifying a more homogeneous subset of rheumatoid
arthritis patients. We also wanted to compare linkage signals when analyzing anti-CCP levels as
dichotomized (CCP_binary), categorical (CCP_cat), and continuous traits, with and without
transformation (log_CCP and CCP_cont). Illumina single-nucleotide polymorphism scans of the
North American Rheumatoid Arthritis Consortium families were analyzed for four chromosomes
(6, 7, 11, 22) using nonparametric linkage (NPL) (rheumatoid arthritis and CCP_binary), regress
(CCP_cat and Log_CCP), and deviates (CCP_cont) analysis options as implemented in Merlin.
Similar linkage results were obtained from analyses of rheumatoid arthritis, CCP_binary, and
CCP_cont. The only exception was that we observed improved linkage signals and a narrower
region for CCP_binary as compared to a clinical diagnosis of rheumatoid arthritis alone on
chromosome 7, a region which previously showed variation in linkage results with rheumatoid
arthritis according to anti-CCP levels. Analyses of CCP_cat and Log_CCP had little power to
detect linkage. Our data suggested that linkage analyses of anti-CCP levels may facilitate
identification of rheumatoid arthritis genes but quantitative analyses did not further improve
power. Our study also highlighted that quantitative trait linkage results are highly sensitive to
phenotype transformation and analytic approaches.
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Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory
autoimmune disease affecting about 1% of the popula-
tion. A genetic component for RA has been well estab-
lished, with the MHC region being the largest single
contributing component. Other chromosome regions
(11q, 10q, 14q, 6p, 6q, 16q, 12p, etc.) and candidate
genes (PTPN22, CTLA4, PADI4) have been identified by
whole-genome linkage scans and association studies [1-
5]. Most recently, a high-density SNP analysis of 642 fam-
ilies affected with RA collected by the North American
Rheumatoid Arthritis Consortium (NARAC), the largest
single linkage study of RA, identified two new linkage
regions, 11p and 2q [6]. These findings reflect the genetic
complexity of the disease and suggest that analysis of a
more homogeneous RA phenotype might increase the
power of linkage analysis. In addition, most previous
studies have analyzed RA as a dichotomous trait, which
could lead to a power loss if RA is a naturally quantitative
trait [7].
Anti-cyclic citrullinated (anti-CCP) antibodies have a high
specificity for RA [8] and the levels are correlated with dis-
ease severity [9,10]. To examine whether the power of
linkage analysis could be improved by analyzing a more
homogeneous phenotype and by quantitative characteri-
zation of the trait, we performed linkage analysis of anti-
CCP antibody levels for selected chromosome regions
previously linked to RA using NARAC data.
Methods
Data set
Illumina SNP scans of the NARAC families were analyzed.
We chose anti-CCP antibody levels as the phenotype of
interest, and evaluated the effect of covariates including
sex, age of onset, year of birth, ever/never smoking, and
current smoking. Anti-CCP antibody levels were analyzed
in three ways: dichotomized, categorical, and continuous.
An antibody titer of 20 was used as a cut-off value to
dichotomize anti-CCP levels into positive (>20) and neg-
ative (≤20). In addition, anti-CCP levels were character-
ized into multiple (four) categories (negative, 0–19.9;
low, 20–49.9; medium, 50–99.9; high, ≥100). Anti-CCP
levels were also analyzed as continuous measurements.
Because the assay for anti-CCP antibody titer has an upper
limit of 210, we recoded all measurements exceeding 210
to 210. A log transformation was applied to approximate
normality of anti-CCP levels because the raw data were
highly skewed.
Chromosome regions
Because the purpose of this study was to compare meth-
ods rather than search for a new locus for anti-CCP, we
limited our linkage analyses to selected regions. Chromo-
somes were selected based on findings from a previous
SNP scan of NARAC families for RA [6]. Chromosome 6,
which contains human lymphocyte antigen (HLA) locus,
was chosen as a positive control region. Chromosome 22,
which did not show evidence for linkage with RA, was
selected as the negative control. Chromosomes 7 and 11,
which showed suggestive and significant evidence for
linkage with RA, respectively, were included in our linkage
analyses as test regions. In particular, it has been shown
that chromosome 7 might harbor a susceptibility locus
that was more closely linked to anti-CCP positive disease
[6].
Linkage analysis
SNPs on chromosomes 6, 7, 11, and 22 were analyzed for
all four anti-CCP phenotypes (CCP_binary, CCP_cat,
Log_CCP, and CCP_cont) as well as RA affection status.
Linkage disequilibrium (LD) between markers was calcu-
lated and markers in LD defined by D' > 0.7 were removed
using SNPLINK [11]. CCP_binary and RA affection were
analyzed by nonparametric (NPL) linkage analysis using
Merlin. CCP_cat and Log_CCP were analyzed by regres-
sion analysis implemented in Merlin Regress, which uses
trait-squared sums and differences to predict IBD sharing
between sib pairs [12]. To run Merlin Regress, it was nec-
essary to specify some trait distribution parameters, such
as mean, variance, and heritability in the general popula-
tion. We did not use the sample mean and variance
because the families were affected with RA and therefore
had higher frequencies and levels of anti-CCP positives.
Instead, we estimated the mean (0 for CCP_cat, 0.78 for
Log_CCP) and variance (0.0088 for CCP_cat, 0.11 for
Log_CCP) among individuals who were anti-CCP nega-
tive (≤20) to approximate the distribution in the general
population. Heritability of 0.6 was estimated based on
variance-component analysis using Merlin. Untrans-
formed continuous anti-CCP levels were also analyzed
using the deviates option implemented in Merlin, which
makes no assumptions about the trait distribution. Again,
we chose 0 to approximate the population mean for anti-
CCP levels.
Results
A total of 746 families containing 1794 affected individu-
als with RA were used for the linkage analyses. There were
only 11 individuals in this data set who were unaffected
with RA. Anti-CCP data was available for 1499 individu-
als. Among the 823 sib pairs with available anti-CCP data,
there were 77 concordant negative, 228 discordant, and
518 concordant positive for anti-CCP. The distribution of
anti-CCP levels was highly skewed toward high positive,
with >50% of the individuals having high anti-CCP levels
when using cut points suggested by the data provider
(Table 1). Male sex and ever smoking were associated with
significantly increased anti-CCP values (t-test p < 0.001
and 0.004, respectively) (Table 2).BMC Proceedings 2007, 1(Suppl 1):S107 http://www.biomedcentral.com/1753-6561/1/S1/S107
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Results obtained from NPL analysis of RA are consistent
with those shown previously by Amos et al. [6]. Overall,
similar linkage signals were obtained from analyses with
RA and CCP_binary, with weaker evidence for linkage
with CCP_binary on chromosomes 6 and 11 (Table 3, Fig-
ure 1). On the other hand, higher LOD scores and
improved definition of a linkage peak for CCP_binary
were observed on chromosome 7 (Figure 1), which has
been suggested to be more closely linked to anti-CCP
compared to RA. Among quantitative anti-CCP levels,
only analysis of untransformed anti-CCP levels showed
comparable results with that of RA. Analyses of either cat-
egorical or log-transformed anti-CCP levels resulted in sig-
nificantly reduced linkage signals for both positive control
(chromosome 6) and test regions (chromosomes 7 and
11). Adjustment of gender and ever smoking in the regres-
sion-based linkage analyses did not significantly change
the results (data not shown). As expected, chromosome
22 did not show evidence for linkage to any of the pheno-
types.
Discussion
In this study, we analyzed anti-CCP levels as dichot-
omized, categorical, and continuous traits in linkage anal-
yses. On chromosome 7, we observed improved linkage
signals and a narrower linkage peak for dichotomized
anti-CCP levels as compared to a clinical diagnosis of RA
alone, although neither analysis reached statistical signif-
icance. Chromosome 7 previously showed stronger evi-
dence for linkage for RA with positive anti-CCP [6].
However, for the three chromosomes we selected that
demonstrated evidence for linkage with RA, analyzing
anti-CCP levels as quantitative traits did not further
improve power to detect linkage compared to RA. In addi-
tion, categorization and log transformation of the contin-
uous phenotype resulted in significantly reduced power to
detect linkage.
Mapping susceptibility genes is challenging for clinically
and genetically heterogeneous diseases such as RA. Exam-
ining a more homogenous disease phenotype might
increase the power of linkage analysis. Anti-CCP is highly
specific for RA and its levels are correlated with disease
severity [9,10]. A previous study suggested genetic varia-
bility according to anti-CCP status on chromosomes 4, 5,
6, and 7 [6]. Our data on chromosome 7 supports the
hypothesis that anti-CCP status might represent a more
genetically homogeneous phenotype of RA. In addition,
although linkage signals on chromosome 11 were less sig-
nificant for the CCP_binary phenotype than RA, linkage
peak regions on both chromosomes 7 and 11 were nar-
rower, suggesting that analyzing anti-CCP levels as a
dichotomous phenotype might be helpful in narrowing
candidate regions in fine mapping.
For naturally occurring continuous or polychotomous
traits, dichotomization could lead to power loss for link-
age analysis [7]. In particular, if the underlying gene con-
fers not only disease susceptibility but also disease
severity, treating disease phenotypes as quantitative traits
could provide additional information in linkage analysis.
We hypothesized that performing quantitative linkage
analyses might increase the power to detect linkage for
anti-CCP levels. However, analyses of none of the three
quantitative phenotypes provided improved linkage sig-
nals compared to NPL analysis of RA. In particular, regres-
Table 1: Distribution of anti-CCP levels among the 1499 
individuals included in the linkage analyses
CCP category N %
Negative 341 22.75
Low 167 11.14
Medium 181 12.07
High 810 54.04
Table 2: Anti-CCP levels by gender, age, year of birth, and smoking status
Covariate Values N anti-CCP mean SD t test P
Sex Female 1153 112.19 102.58 <0.001
Male 346 143.24 100.19
Age of onset <40 758 119.70 97.53
≥40 722 119.89 108.01 nsa
Year of birth <1944 754 119.34 97.53
≥1944 738 119.50 108.01 ns
Smoking Never 618 110.54 100.38
Ever 832 126.13 104.91 0.004
Current 244 119.84 105.32
Never or former 1211 119.44 102.79 ns
ans, not significantBMC Proceedings 2007, 1(Suppl 1):S107 http://www.biomedcentral.com/1753-6561/1/S1/S107
Page 4 of 5
(page number not for citation purposes)
sion-based quantitative linkage analyses of log-
transformed or ordinal anti-CCP levels, with or without
covariate adjustment, appeared to have reduced power to
detect linkage compared to NPL analysis of dichotomized
anti-CCP status. We also used the variance components
and quantitative trait locus analysis options implemented
Linkage analyses of 4 chromosomes for RA and anti-CCP levels using SNPs Figure 1
Linkage analyses of 4 chromosomes for RA and anti-CCP levels using SNPs. LOD scores for binary outcomes (RA, 
CCP_binary), transformed quantitative traits (CCP_cat, Log_CCP), and untransformed quantitative trait (CCP_cont) were cal-
culated using Merlin NPL, Merlin Regress, Merlin --deviates, respectively. The scale of the Y-axis for chromosome 6 is different.
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Table 3: Maximal LOD scores for RA and anti-CCP phenotypes in the four chromosome regions
Chromosome RA CCP binary CCP categorical Log CCP CCP continuous
6 17.86 15.01 7.26 11.10 15.77
7 1.46 1.93 0.65 0.64 1.30
11 3.22 2.56 0.62 0.34 3.30
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in Merlin for CCP_cat and Log_CCP phenotypes and
observed similar results. For this particular trait, trans-
forming the phenotype to achieve normality reduced the
signal due to the major locus. Alternate approaches to
handle non-normality are needed for quantitative trait
linkage analysis in selected samples. Consistent with
another report [13], we found loss of power when treating
CCP_cat as continuous. Novel approaches, such as the
recently proposed proportional odds latent variable
model by Feng et al. [14], need to be further explored.
Finally, all these quantitative linkage analyses are very
sensitive to the specification of population parameters,
such as population mean and variance, chosen for the
regress and deviates analyses. Replacement of the estimated
population mean by the sample mean or default values
set by the programs resulted in completely different LOD
scores. These results further highlight the importance of
precise estimates and appropriate analytical approaches
in linkage analysis of quantitative traits.
Conclusion
Linkage analyses of anti-CCP levels may facilitate identifi-
cation of RA genes by making the phenotype more homo-
geneous. However, quantitative analyses of anti-CCP
levels did not improve power to detect linkage over anal-
ysis of RA. Furthermore, log transformation and categori-
zation of anti-CCP levels resulted in reduced power to
detect linkage.
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